Muscle dysfunction associated with adjuvant-induced arthritis is prevented by antioxidant treatment by Takashi Yamada et al.
Yamada et al. Skeletal Muscle  (2015) 5:20 
DOI 10.1186/s13395-015-0045-7RESEARCH Open AccessMuscle dysfunction associated with
adjuvant-induced arthritis is prevented by
antioxidant treatment
Takashi Yamada1*, Masami Abe1, Jaesik Lee1, Daisuke Tatebayashi1, Koichi Himori1, Keita Kanzaki2, Masanobu Wada3,
Joseph D. Bruton4, Håkan Westerblad4 and Johanna T. Lanner4Abstract
Background: In addition to the primary symptoms arising from inflamed joints, muscle weakness is prominent and
frequent in patients with rheumatoid arthritis (RA). Here, we investigated the mechanisms of arthritis-induced
muscle dysfunction in rats with adjuvant-induced arthritis (AIA).
Methods: AIA was induced in the knees of rats by injection of complete Freund’s adjuvant and was allowed to
develop for 21 days. Muscle contractile function was assessed in isolated extensor digitorum longus (EDL) muscles.
To assess mechanisms underlying contractile dysfunction, we measured redox modifications, redox enzymes and
inflammatory mediators, and activity of actomyosin ATPase and sarcoplasmic reticulum (SR) Ca2+-ATPase.
Results: EDL muscles from AIA rats showed decreased tetanic force per cross-sectional area and slowed twitch
contraction and relaxation. These contractile dysfunctions in AIA muscles were accompanied by marked decreases
in actomyosin ATPase and SR Ca2+-ATPase activities. Actin aggregates were observed in AIA muscles, and these
contained high levels of 3-nitrotyrosine and malondialdehyde-protein adducts. AIA muscles showed increased
protein expression of NADPH oxidase 2/gp91phox, neuronal nitric oxide synthase, tumor necrosis factor α (TNF-α),
and high-mobility group box 1 (HMGB1). Treatment of AIA rats with EUK-134 (3 mg/kg/day), a superoxide dismutase/
catalase mimetic, prevented both the decrease in tetanic force and the formation of actin aggregates in EDL muscles
without having any beneficial effect on the arthritis development.
Conclusions: Antioxidant treatment prevented the development of oxidant-induced actin aggregates and contractile
dysfunction in the skeletal muscle of AIA rats. This implies that antioxidant treatment can be used to effectively
counteract muscle weakness in inflammatory conditions.
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Patients with rheumatoid arthritis (RA) show significant
muscle weakness, and this has a major impact on the
disability in these patients [1]. Loss of muscle strength in
RA patients was traditionally attributed to a disuse atro-
phy caused by joint deformity and pain [2]. However,
functional studies show that decreased specific force
(i.e., force per cross-sectional area) makes an equally im-
portant contribution to the overall weakness in RA* Correspondence: takashi.yamada1976@sapmed.ac.jp
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creativecommons.org/publicdomain/zero/1.0/patients [3, 4]. Moreover, we reported a marked depres-
sion in maximal specific force in both fast-twitch exten-
sor digitorum longus (EDL) and flexor digitorum brevis
and slow-twitch soleus muscle from collagen-induced
arthritis (CIA) mice, a widely used animal model for RA
[5, 6]. It is worth noting that intrinsic contractile proper-
ties of fast-twitch muscle are little affected in animal
models of disuse [7, 8].
The peroxynitrite anion (ONOO−) is an oxidant formed
when nitric oxide (NO) reacts with superoxide. We previ-
ously showed that the depressed myofibrillar force pro-
duction in CIA muscles was accompanied by an increased
3-nitrotyrosine (3-NT) content [5, 6], which is regardedarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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addition, ONOO− exposure depressed Ca2+-activated
force production in skinned muscle fibers from rat
[10]. Thus, impaired myofibrillar function mediated by
ONOO− is likely to be important in arthritis-induced
muscle dysfunction. Furthermore, Tiago et al. [11]
showed that actin is more sensitive to ONOO− than
other proteins in the contractile machinery (i.e., myofi-
brillar proteins including myosin) and that ONOO−-in-
duced oxidation of actin inhibits the ability of actin to
stimulate actomyosin ATPase activity.
EUK is a novel cell-permeable manganese-salen (Mn-
Salen) compound, which mimics the catalytic function
of superoxide dismutase (SOD) and catalase. EUK has
been shown to eliminate not only superoxide and hydro-
gen peroxide [12] but also NO-derived radicals, includ-
ing ONOO− via additional oxidation of EUK [13].
Several studies have shown that administration of EUK
protects against oxidative stress-induced muscle weak-
ness and wasting in various conditions [14–16]. Specific-
ally, EUK-134 prevented reductions in specific force
generation in the diaphragm muscle of mdx mice [15].
Here, we examined mechanisms underlying arthritis-
induced muscle weakness, focusing on the role of redox
stress on contractile properties in fast-twitch EDL mus-
cles. The major results show oxidant-induced actin ag-
gregates and contractile dysfunction in muscles of rats
with adjuvant-induced arthritis (AIA), and these deleteri-
ous changes were prevented when rats were treated with
the antioxidant EUK-134.Methods
Ethical approval
All experimental procedures were approved by the Com-
mittee on Animal Experiments of Sapporo Medical Univer-
sity. Animal care was in accordance with the institutional
guidelines.Induction of adjuvant-induced arthritis
Male Lewis rats (8-week old, n = 28) were supplied by
Sankyo Labo Service (Sapporo, Japan). Rats were given
food and water ad libitum and housed in an environmen-
tally controlled room (24 ± 2 °C) with a 12-h light-dark
cycle. AIA was induced in the knees by an intraarticular
injection of 0.2 ml of cocktail containing Freund’s incom-
plete adjuvant (DIFCO) and 2 mg Mycobacterium butyri-
cum (DIFCO) under sodium pentobarbital (40 mg/kg)
anesthesia. Some rats were treated with the superoxide
dismutase/catalase mimetic EUK-134 (Calbiochem). EUK-
134 was dissolved in phosphate-buffered saline (PBS) at
2 mg/ml, and rats were injected intraperitoneally at a dose
of 3 mg/kg/day starting 1 day after induction of AIA. PBS
was injected as a control.Three weeks after induction of AIA, rats were killed
by an overdose of sodium pentobarbital (120 mg/kg).
The maximum diameters of the knee joint were mea-
sured with a Mitutoyo caliper. The fast-twitch extensor
digitorum longus (EDL) muscles were excised; in some
experiments, we also excised slow-twitch soleus muscles.
Measurement of isometric contractile force
The force-frequency relationship was established in in-
tact EDL and soleus muscles, as described previously
[5]. For twitch contractions, the peak rate of tension de-
velopment (+dP/dt, maximal positive slope of the force
record determined over a 10-ms moving window) and
the peak rate of tension decline (−dP/dt, maximum
negative slope of the force record measured over a 10-
ms moving window) were determined. Absolute force
was normalized to cross-sectional area, calculated as
muscle weight divided by the length giving maximum
tetanic force and density (1056 kg m−3).
Myosin heavy chain and actin content in myofibrillar
proteins
Extraction of myofibrils was performed as previously de-
scribed [17]. Myofibrillar proteins were separated by a
10 % SDS-PAGE gel. Aliquots of myofibrillar extracts
containing 5 μg of protein were subjected to electro-
phoresis and stained with Coomassie brilliant blue. Im-
ages of gels were acquired using the GelDoc imaging
system (Bio-Rad). The relative content of myosin heavy
chain (MyHC) or actin in total myofibrillar proteins was
evaluated densitometrically using ImageJ.
MyHC isoforms separation
Aliquots of the extracts containing 5 μg myofibrillar pro-
tein were applied for MyHC electrophoresis as previously
described in detail [18]. Using a 6 % polyacrylamide slab
gel, electrophoresis was run at 4 °C for 48 h at 160 V and
stained with Coomassie brilliant blue. Images of gels were
densitometrically evaluated with ImageJ.
Actomyosin ATPase activity
Actomyosin ATPase activity was spectrophotometrically
determined in myofibrillar extracts at 37 °C using a pre-
viously described assay [17]. Western blotting confirmed
that the myofibrillar extracts contained no sarcoplasmic
reticulum (SR) Ca2+-ATPase (SERCA) (data not shown).
An aliquot of myofibrillar extracts was added to the re-
action mixture (mM): KCl, 30; Tris, 30; sodium azide, 2;
MgSO4, 1; EGTA, 1; CaCl2, 1.1; NADH, 0.4; phospho-
enolpyruvate, 10; 18 U/ml pyruvate kinase; and 18 U/ml
lactate dehydrogenase. The reaction was then started by
adding Na-ATP to give a final concentration of 1 mM.
The oxidation of NADH was monitored in a spectro-
photometer (340 nm) for 3 min. Actomyosin ATPase
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brillar proteins.
Sarcoplasmic reticulum Ca2+-ATPase activity
Muscle pieces were homogenized in ice-cold homogen-
izing buffer (9 μl/mg wet wt) consisting of (mM): su-
crose, 300; Mops/KOH, 20; and one tablet of protease
inhibitor cocktail (Roche) per 50 ml (pH 7.4). The lysate
was then centrifuged at 5000g for 10 min. The protein
content of the supernatant was determined using Bradford
assay [19] and stored at −80 °C. SERCA activity was mea-
sured as described previously [20]. Briefly, aliquots of the
supernatant (20 μl) were applied to the assay mixture
(mM): Hepes, 20; EGTA, 1; KCl, 200; MgCl2, 15; CaCl2,
0.8; NaN3, 10; NADH, 0.4; phosphoenolpyruvate, 10;
12.1 U/ml pyruvate kinase; 20.2 U/ml lactate dehydro-
genase; and 1 μg/ml Ca2+ ionophore A23187 (Sigma)
(pH 7.1). The reaction was initiated by adding Mg-ATP
at a final concentration of 4 mM. Finally, the CaCl2
concentration was increased to 20 mM to selectively
inhibit SERCA activity. The remaining activity was de-
fined as the background ATPase activity. The activity of
SERCA was calculated as the difference between the total
and the background ATPase activities and expressed as
millimole/minute/gram cytoplasmic proteins.
Immunoblots
Crude muscle homogenates were separated by electro-
phoresis and transferred onto membranes. Membranes
were incubated with primary antibody (anti-ryanodine
receptor 1 (RyR1), MA3-925, Thermo; anti-dihydropyridine
receptor (DHPR) α2 subunit, ab2864, Abcam; anti-SERCA1,
MA3-911, Thermo; anti-SERCA2, ab3625, Abcam; anti-
actin, A4700, Sigma; anti-troponin I, MAB1691, Millipore;
anti-3-NT, ab52309, Abcam; anti-malondialdehyde (MDA),
MD20A-R1a, Academy Bio-Medical; anti-tumor necrosis
factor α (TNF-α), 11948, Cell Signaling; anti-high-mobility
group box 1 (HMGB1), 326059652, SHINO-TEST; anti-
NADPH oxidase 2 catalytic subunit gp91phox (NOX2/
gp91phox), ab31092, Abcam; anti-neuronal, anti-endothelial,
and anti-inducible nitric oxide synthases (nNOS, eNOS,
and iNOS, respectively), 610308, 610296, 610328, respect-
ively, BD Biosciences; anti-manganese SOD (SOD2),
06-984, Upstate). Images of the membrane were col-
lected following exposure to chemiluminescence sub-
strate (Millipore) using a charge-coupled device camera
attached to ChemiDOC MP (Bio-Rad), and Image Lab
Software was used for detection as well as densitometry.
Statistics
Data are presented as mean ± SEM. Student’s unpaired t
tests, as well as one-way ANOVA and one-way repeated
measures ANOVA, were used to determine statistically
significant differences as appropriate. A Bonferroni posthoc test was used when significant differences were de-
termined using ANOVA. A P value less than 0.05 was
regarded as statistically significant.Results
Knee width, body weights, and muscle weights
All rats exposed to intraarticular knee injection of
Freund’s incomplete adjuvant and Mycobacterium butyr-
icum developed AIA, and the maximum diameter of the
knee joint of AIA rats was significantly increased by
20 % compared to the control rats (11.8 ± 0.3 versus 9.7 ±
0.1 mm (n = 6); P < 0.01). The body weights of the rats
with AIA were significantly lower than those of the con-
trol group (271 ± 9 versus 320 ± 6 g (n = 6); P < 0.01). In
addition, absolute EDL muscle weight was ~10 % lower in
the rats with AIA than that in controls (115 ± 5 versus
128 ± 3 mg (n = 6); P < 0.05), but this difference disap-
peared when muscle weight was normalized to body
weight (0.4 ± 0.01 versus 0.4 ± 0.01 mg/g (n = 6); P > 0.05).
For the soleus muscles, both the absolute and the normal-
ized muscle weights were significantly lower in the rats
with AIA than in the control rats (75 ± 6 versus 117 ±
2 mg (n = 6–7); P < 0.01; 0.28 ± 0.01 versus 0.36 ± 0.01 mg/
g (n = 6–7); P < 0.01).AIA causes a decreased actomyosin ATPase and SERCA
activity
There was no difference in the total myofibrillar protein
concentration in EDL muscles between the rats with AIA
and control rats (130.0 ± 5.7 versus 120.0 ± 13.4 mg/g wet
wt (n = 7–8); P > 0.05). A minor reduction in MyHC, but
not actin, protein expression has been observed in CIA so-
leus muscle [5]. We therefore assessed the expression
levels of MyHC and actin. Figure 1a shows a typical ex-
pression pattern of these myofibrillar proteins in control
and AIA muscles. Neither the MyHC nor actin content
was altered in AIA muscles compared with control mus-
cles (Fig. 1b).
In contrast, the actomyosin ATPase activity in muscles
of AIA rats was reduced to ~70 % than that in controls
(Fig. 1c). Rat EDL muscles are composed mainly of fast-
twitch fibers (Fig. 1d). There were no significant differ-
ences in the distribution of the MyHC isoforms between
the control rats and rats with AIA (Fig. 1e). Thus, the de-
creased actomyosin ATPase activity observed in our study
was not due to changes in the expression of MyHC
isoforms.
There were no changes in the expression levels of the
Ca2+-handling proteins RyR1, DHPR, or SERCA1 (Fig. 1f,
g), whereas SERCA2 was not detected in either group.
In contrast, SERCA activity was ~30 % lower in AIA
than that in control EDL muscles (Fig. 1h). Thus, AIA
muscles display impaired intrinsic function of both SERCA
Fig. 1 Actomyosin ATPase and sarcoplasmic reticulum (SR) Ca2+-ATPase activities are decreased in AIA EDL muscles. Representative Coomassie
brilliant blue staining of myofibrillar proteins (a), percentage distribution of myosin heavy chain (MyHC) and actin content in total myofibrillar
proteins (b), and actomyosin ATPase activity (c). Electrophoretically separated MyHC isoforms (d) and percentage distribution of MyHC isoforms
(e): I, slow isoform and IIa, IId/x, and IIb, fast isoforms. Representative Western blots of ryanodine receptor (RyR1), dihydropyridine receptor α2
subunit (DHPR), and SR Ca2+-ATPase (SERCA) 1 (f), the expression levels of these proteins normalized to actin content (g), and SERCA activity (h).
Control (CNT), white bars; AIA, black bars. Data are presented as mean ± SEM for three to seven muscles in each group. *P < 0.05 versus CNT
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muscle.
Antioxidant does not prevent arthritis but protects
against AIA-induced muscle weakness
There was no significant difference in the absolute
twitch force of the EDL muscle between the rats with
AIA and control rats (0.38 ± 0.02 versus 0.37 ± 0.02 N
(n = 6); P > 0.05) (Fig. 2a). In contrast, the rates of forcedevelopment (dP/dt) and relaxation (–dP/dt) in twitches
were decreased by 27 and 29 % in AIA EDL muscles, re-
spectively (Fig. 2a, b). Absolute tetanic force was ~20 %
lower in AIA EDL muscles than that in controls at stimu-
lation frequencies from 70 to 120 Hz (Fig. 2c). Although
the cross-sectional area of AIA EDL muscles was some-
what decreased, tetanic force per cross-sectional area (i.e.,
specific force) was ~15 % lower than in control muscles at
100 and 120 Hz (P < 0.05 and P < 0.01, respectively)
Fig. 2 Antioxidant treatment prevents contractile dysfunction in AIA EDL muscles. Representative original records of twitch (a) and 100 Hz tetanic
(c) force from a control (CNT, dashed line) and an AIA (full line) EDL muscle. The peak rates of twitch force development (dP/dt) and relaxation
(−dP/dt) (b) and specific force-frequency relationship (d) in CNT and AIA EDL muscles. Maximum knee diameter (e) and specific force-frequency
relationship (f) in EDL muscles from CNT and AIA rats with or without treatment with EUK-134 (EUK). Data are presented as mean ± SEM for four
to seven muscles in each group. *P < 0.05, **P < 0.01 versus CNT, ##P < 0.01 versus AIA
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force-frequency relationship in AIA EDL muscles with the
frequency giving 50 % of the maximum force being signifi-
cantly lower than in control muscles (31.9 ± 1.7 versus
40.9 ± 1.6 Hz (n = 6); P < 0.05).
In addition, there was a marked reduction in the spe-
cific force in AIA soleus muscles at stimulation fre-
quency from 10 to 120 Hz (ranging from −33 to −42 %
(n = 6–7); P < 0.01). Moreover, twitches were slower inAIA soleus muscles with dP/dt and –dP/dt being de-
creased by 27 and 34 %, respectively (n = 5–7; P < 0.05).
No further experiments were performed on the soleus
muscles. Thus, decreased tetanic force production and
slowed twitch contractions are observed in both fast-
twitch and slow-twitch muscles of AIA rats, which is
consistent with previous results from CIA mice [5, 6].
We and others have proposed redox protein modifica-
tion as one of the mechanisms underlying the intrinsic
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tory conditions [5, 6, 21]. Therefore, we studied whether
antioxidant treatment could prevent the arthritis-induced
muscle weakness. AIA rats were then treated with the
SOD/catalase mimetic EUK-134, which was injected intra-
peritoneally once daily starting the day after induction of
AIA. EUK-134 treatment had no obvious effect on the de-
velopment of arthritis, and the increase in the maximum
diameter of the knee joint was similar in EUK-134-treated
and PBS-injected control AIA rats (Fig. 2e). Nevertheless,
the decrease in specific tetanic force was prevented in the
EUK-134-treated AIA rats (Fig. 2f).
Antioxidant inhibits redox modifications of actin in
muscles from AIA rat
Due to previous results [5, 6, 21] and the present result
that antioxidant treatment prevented muscle weakness
in AIA rats, we next investigated whether the contractile
defects were accompanied by signs of changed redox sta-
tus in the AIA EDL muscle. MDA is a highly reactive by-
product of lipid peroxidation. Western blotting showed
several positive bands for MDA-protein adducts in both
control and AIA muscles. Among these bands, EDL mus-
cles from the rats with AIA showed a specific increase in
MDA-protein adducts at ~150 kDa (Fig. 3a, d). 3-NT isFig. 3 Malondialdehyde-protein adducts and 3-nitrotyrosine content are in
Western blots for malondialdehyde (MDA)-protein adducts (a), 3-nitrotyrosi
the 3-NT and actin blots, samples from AIA rats were run in the absence an
band at ~150 kDa (indicated by the arrows) in MDA-protein adducts, 3-NT,
presented as mean ± SEM for six muscles in each group. *P < 0.05, **P < 0.0considered to be a major product of peroxynitrite-derived
radical interaction with tyrosine residues in proteins [9].
There was also a marked increase in 3-NT protein content
at ~150 kDa in AIA muscles (Fig. 3b, d). It has previously
been demonstrated that oxidative stress can induce the
formation of actin aggregates [22]. In addition to the nor-
mal actin band seen at ~40 kDa, Western blots for actin
showed a strong band at ~150 kDa in AIA muscles (Fig. 3c,
d). It should be noted that the appearance of the ~150 kDa
band in AIA muscles was not accompanied by any detect-
able decrease in the major ~40 kDa actin band, which
shows that normally sized actin was still dominating. Intri-
guingly, the ~150 kDa bands for 3-NT and actin in AIA
muscles disappeared when Western blotting was per-
formed in the presence of the 2-mercaptoethanol (ME),
which reduces disulfide bonds (Fig. 3b, c). Taken together,
these results indicate the formation of ~150 kDa MDA-
and 3-NT-containing and disulfide bond-dependent actin
aggregates in AIA muscles.
The contractile deficiency was prevented when AIA
rats were treated with the antioxidant EUK-134 (see
Fig. 2f ) and AIA muscles displayed major redox-induced
actin modifications. Thus, we studied the effect of EUK-
134 treatment on actin aggregates in EDL muscles of
AIA rats. Importantly, the results show that the increasecreased in actin aggregates from AIA EDL muscles. Representative
ne (3-NT) (b), and actin (c) in control (CNT) and AIA EDL muscles. In
d presence of 2-mercaptoethanol (ME). d Intensities for the protein
and actin were normalized to the troponin I (TnI) content. Data are
1 versus CNT
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muscles was prevented by EUK-134 treatment (Fig. 4a–c).
Increased amount of redox-related proteins and
inflammatory mediators in muscles from AIA rats
ONOO− is formed by the rapid, diffusion-controlled re-
action of NO and superoxide. To assess the molecular
mechanism of the accelerated production of ONOO− in
the AIA muscle, as indicated by the increased ~150 kDa
3-NT band, the expression of redox-related proteins
were analyzed. The expressions of NOX2/gp91phox and
nNOS, but not eNOS, were significantly increased in
AIA EDL muscles (Fig. 5a, b). iNOS was not detected in
either group, and the expression levels of SOD2 were
similar in the two groups.
We also measured the protein expression of the inflam-
matory mediators TNF-α and HMGB1, both of which
have been suggested to induce redox stress [3, 23]. TheFig. 4 Antioxidant treatment of AIA rats prevents redox modifications of ac
(3-NT) (a) and actin (b) in EDL muscles from control (CNT) and AIA rats wit
band at ~150 kDa (indicated by arrows) in 3-NT and actin were normalized
four muscles in each group. **P < 0.01 versus CNT, ##P < 0.01 versus AIAprotein expressions of both TNF-α and HMGB1 were sub-
stantially higher in AIA than in control EDL muscles
(Fig. 5a, b).
Discussion
We found a reduction in specific force production and
slowed contractions in fast-twitch as well as slow-twitch
muscles from the rats with AIA, which is consistent with
our previous studies in CIA mice [5, 6]. Thus, in addition
to muscle atrophy, impaired intrinsic contractility is a
major cause of weakness in skeletal muscles of animal
models of RA as well as in patients with RA [4]. Import-
antly, we here show that the decrease in force production
was prevented when AIA rats were treated with the anti-
oxidant EUK-134.
TNF-α-induced weakness has been shown to be medi-
ated by an increase in muscle-derived oxidants, includ-
ing NO derivatives [3]. Accordingly, brief exposure totin in EDL muscles. Representative Western blots for 3-nitrotyrosine
h or without treatment with EUK-134 (EUK). c Intensities for the protein
to the troponin I (TnI) content. Data are presented as mean ± SEM for
Fig. 5 Expressions of redox-related proteins and inflammatory
mediators are altered in AIA EDL muscles. a Representative Western
blots illustrating the levels of NADPH oxidase (NOX2/gp91phox),
neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS),
superoxide dismutase 2 (SOD2), tumor necrosis factor α (TNF-α), and
high-mobility group box 1 (HMGB1) in control (CNT) and AIA EDL
muscles. The inducible NOS was not detected in either group.
b Quantification of the levels of redox-related proteins normalized
to actin content. Data are presented as mean ± SEM for three to six
muscles in each group. *P < 0.05, **P < 0.01 versus CNT
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force, and nNOS has been identified as the source of
TNF-α-stimulated NO production in the skeletal muscle
from guinea pig [24] and mouse [25], respectively. In
agreement, we observed decreased specific force accom-
panied by increased levels of TNF-α and nNOS expres-
sion in AIA EDL muscles. Conversely, iNOS was not
detected in AIA muscles in the present study. TNF-α, in
combination with interferon (IFN)-γ, stimulates iNOS
expression in C2C12 myocytes [26]. However, the expres-
sion of iNOS was increased directly after endotoxine injec-
tion and thereafter returned to baseline within ~24 h [27].
Our experiments were performed 3 weeks after induction
of inflammation; hence, our data suggest that nNOS is the
most important NOS isoform for the TNF-α-induced im-
paired contractility in chronic inflammatory conditions.
In addition to the NO derivatives, previous studies
show that TNF-α stimulates superoxide production in
the skeletal muscle via the mitochondrial electron trans-
port chain [28] and phospholipase A2 [24]. TNF-α is alsoknown to stimulate NADPH oxidases in human rheuma-
toid synovial tissue [29], which are enzymes that reduce
molecular oxygen to superoxide [30], and we here show
increased NOX2/gp91phox protein expression in AIA
muscles. Increased HMGB1 protein expression has been
observed in the rat diaphragm with peritonitis, which
was accompanied by signs of severe oxidative stress and
contractile dysfunction [23]. We have previously shown
that the stimulation with IFN-γ results in increased ex-
pression of HMGB1 in skeletal muscle fibers [31]. Thus,
the upregulation of TNF-α and HMGB1 protein expres-
sion observed in the present AIA muscles is likely to
cause increased superoxide production.
An intriguing finding of this study is the redox-
dependent actin aggregates in AIA EDL muscles, which
are most likely formed by disulfide bonds since they
were reversed by the reducing agent 2-ME (see Fig. 3).
The high amount of 3-NT, a product of tyrosine nitra-
tion mediated by ONOO−, in aggregated actin indicates
a coordinated increase in NO and superoxide produc-
tion in AIA muscles. The present results fit with a model
where increased production of nNOS-derived NO and
NOX2/gp91phox-derived superoxide favors ONOO− pro-
duction. Alternatively, nNOS is known to produce both
NO and superoxide and may directly increase ONOO−
production [32]. Using a rat model of acute oxidative
stress in the skeletal muscle, Fedorova et al. [22] de-
tected actin-containing protein aggregates above a mo-
lecular mass of 100 kDa. Cys272 of the actin molecule is
easily oxidized to sulfenic acid, slowly forming an intra-
molecular disulfide bond with Cys374, which alters the
structure and exposes Cys17 to forming intermolecular
disulfides [33]. Subsequently, Fedorova et al. [34] showed
that carbonylation of actin results in significant reduc-
tion in actomyosin ATPase activity. Consistent with this,
we observed a strong MDA band, which has been asso-
ciated with increased protein carbonylation [35], at the
same size (~150 kDa) as the actin aggregates. Further-
more, it has been shown that treatment of fibrillary (F)-
actin with peroxynitrite donor produces a dose-dependent
F-actin depolymerization and eventually impairs mono-
meric/F-actin equilibrium, leading to shortening of the
actin filaments to a size smaller than that needed to acti-
vate myosin S1-ATPase [11]. Thus, these data suggest that
the decreased actomyosin ATPase activity in AIA muscles
is likely to be caused by redox modifications of actin.
Mn-Salen compounds, including EUK-134, have been
proposed to possess distinct advantages over nonspecific
antioxidant scavengers, such as combined SOD/catalase
mimetic functions [12] and high translational value as
the EUK series is developed for oral administration [36].
In addition to counteracting oxidative stress, Mn-Salen
catalyzes the removal of ONOO− and ameliorates nitro-
sative stress [13]. In a previous report, administration of
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tially rescued a reduction in specific force production in
the diaphragm from mdx mice [15]. We report here that
daily intraperitoneal injection of EUK-134 prevented the
AIA-induced 3-NT formation, aggregation of actin, and
force depression. These results strongly support our no-
tion that the oxidative/nitrosative modifications of actin
result in contractile dysfunction in AIA muscles.
Previous studies provide evidence for a role of redox
stress in the pathogenesis of RA [37]. Thus, we expected
that treatment with EUK-134 would prevent the develop-
ment of both arthritis and muscle weakness. However, the
increase in knee diameter in AIA rats was not prevented
by EUK-134 treatment (see Fig. 2e). The reason for this is
unclear but could be due to the tissue-dependent differ-
ences in the levels of oxidative stress and/or concentration
of EUK-134. AIA was induced in the knees by direct
intraarticular injection of Freund’s complete adjuvant, and
the oxidative stress might then be higher in these joints
than in adjacent skeletal muscles. In contrast, EUK-134
was not specifically targeted to the afflicted joints since it
was administered by intraperitoneal injections. Thus, it is
conceivable that the concentration of EUK-134 in the knee
joints did not reach high enough levels to prevent the de-
velopment of arthritis.
In addition to decreased actomyosin ATPase activity,
we also show decreased SERCA activity in the AIA
muscle, which was not accompanied by any change in
SERCA protein expression. This finding is consistent
with the previous work by Strosova et al. [38] showing a
redox-induced decrease in SERCA activity in the AIA
skeletal muscle, which was not accompanied by decreased
SERCA protein expression. Moreover, exposure to ONOO
− has been shown to depress SERCA activity [39]. Thus,
increased ONOO− production may have a central role in
the decrease of both actomyosin ATPase and SERCA ac-
tivities in AIA muscles. These alterations may account for
the compromised contractility of AIA muscles; for in-
stance, a decreased rate of cross-bridge cycling and SR
Ca2+ uptake may directly explain the slowed twitch kinet-
ics and a left-ward shift of force-frequency relationship in
AIA muscles (see Fig. 2a–d).
Conclusions
Using AIA rats, we show that arthritis can cause intrin-
sic contractile dysfunction in skeletal muscles. This dys-
function is likely to be induced by increased levels of the
pro-inflammatory mediators TNF-α and HMGB1, which
result in increased NO and superoxide production. This
then leads to the formation of actin aggregates and de-
creased actomyosin ATPase activity and to impaired
SERCA function. These deleterious changes were pre-
vented by treating AIA rats with the antioxidant EUK-
134, which then provides a tentative treatment of muscleweakness in patients with arthritis or other inflammatory
diseases.
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